Ordering Recommendation

Acceptable panel to detect the two most common inherited thrombophilias (prothrombin related and factor V Leiden related).

Mnemonic
THROMDNA
Methodology

Polymerase Chain Reaction/Fluorescence Monitoring

Performed

Sun-Sat

Reported

2-6 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Lavender (EDTA), pink (K2 EDTA) or yellow (ACD Solution A or B).

Specimen Preparation

Transport 3 mL whole blood. (Min: 2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Plasma or serum; collection of specimen in sodium heparin tubes.

Remarks
Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month.

Reference Interval
Test Number
Components
Reference Interval
0097720 Factor V Leiden (F5) R506Q Mutation Negative: This sample is negative for factor V Leiden, R506Q mutation.
0055655 Methylenetetrahydrofolate Reductase (MTHFR) 2 Variants Negative: Neither of the MTHFR variants tested, c.665C>T (previously designated C677T) and c.1286A>C (previously designated A1298C), were detected. Other causes of elevated homocysteine levels were not evaluated.
0056060 Prothrombin (F2) c.*97G>A (G20210A) Pathogenic Variant

Interpretive Data

Refer to report

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Compliance Category

Laboratory Developed Test (LDT)

Note
Hotline History
N/A
CPT Codes

81240; 81241; 81291

Components
Component Test Code* Component Chart Name LOINC
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • FVL R506Q, MTHFR, and Factor II mutation panel
  • Hypercoag
  • Hypercoagulable Panel
Thrombotic Risk, DNA Panel